| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |